OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Deciphering the Effects and Mechanisms of Yi-Fei-San-Jie-pill on Non-Small Cell Lung Cancer With Integrating Network Target Analysis and Experimental Validation
Hongxing Yang, Qiuyan Guo, Jianbin Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Hongxing Yang, Qiuyan Guo, Jianbin Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Showing 12 citing articles:
Glycyrrhetinic acid inhibits non-small cell lung cancer via promotion of Prdx6- and caspase-3-mediated mitochondrial apoptosis
Qiuyan Guo, Minghong Zhao, Qixin Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116304-116304
Open Access | Times Cited: 7
Qiuyan Guo, Minghong Zhao, Qixin Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116304-116304
Open Access | Times Cited: 7
A novel fluorinated polyethyleneimine with microRNA-942-5p-sponges polyplex gene delivery system for non-small-cell lung cancer therapy
Yi Jin, Wei Yu, Wenkai Zhang, et al.
Journal of Colloid and Interface Science (2023) Vol. 648, pp. 287-298
Closed Access | Times Cited: 16
Yi Jin, Wei Yu, Wenkai Zhang, et al.
Journal of Colloid and Interface Science (2023) Vol. 648, pp. 287-298
Closed Access | Times Cited: 16
Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway
Tianming Lu, Lirun Zhou, Zheng Chu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Tianming Lu, Lirun Zhou, Zheng Chu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model
Qianyu Zhang, Ying Zhang, Chen Wang, et al.
Phytomedicine (2024) Vol. 129, pp. 155657-155657
Closed Access | Times Cited: 5
Qianyu Zhang, Ying Zhang, Chen Wang, et al.
Phytomedicine (2024) Vol. 129, pp. 155657-155657
Closed Access | Times Cited: 5
Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway
Caizhi Yang, Wei Guo, Yifan Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116566-116566
Closed Access | Times Cited: 6
Caizhi Yang, Wei Guo, Yifan Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116566-116566
Closed Access | Times Cited: 6
Mechanistic insights into Yifei Sanjie pill's regulation of EMT to enhance gefitinib treatment effect in NSCLC by in silico analysis and experimental validation
Rui-Sheng Zhou, Binyu Qin, Zhenjie Zhuang, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118343-118343
Closed Access | Times Cited: 1
Rui-Sheng Zhou, Binyu Qin, Zhenjie Zhuang, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118343-118343
Closed Access | Times Cited: 1
Yi-Fei-San-Jie Chinese medicine formula reverses immune escape by regulating deoxycholic acid metabolism to inhibit TGR5/STAT3/PD-L1 axis in lung cancer
Zhiqiang Chen, Xiwu Rao, Lingling Sun, et al.
Phytomedicine (2024) Vol. 135, pp. 156175-156175
Open Access | Times Cited: 1
Zhiqiang Chen, Xiwu Rao, Lingling Sun, et al.
Phytomedicine (2024) Vol. 135, pp. 156175-156175
Open Access | Times Cited: 1
Cell-Derived Allograft Models as a Solution to the Obstacles of Preclinical Studies under Limited Resources: A Systematic Review on Experimental Lung Cancer Animal Models
I Nyoman Bayu Mahendra, Ahmad Kurniawan, Muhamad Basit Febrian, et al.
Current Reviews in Clinical and Experimental Pharmacology (2024) Vol. 20, Iss. 1, pp. 49-59
Closed Access
I Nyoman Bayu Mahendra, Ahmad Kurniawan, Muhamad Basit Febrian, et al.
Current Reviews in Clinical and Experimental Pharmacology (2024) Vol. 20, Iss. 1, pp. 49-59
Closed Access
Inhibition of ALDOA and ENO1‐mediated Glycolysis of Oridonin as a Novel Anti‐tumor Strategy of Non‐small Cell Lung Cancer
Tianming Lu, Qixin Wang, Minghong Zhao, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 6
Closed Access
Tianming Lu, Qixin Wang, Minghong Zhao, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 6
Closed Access
Bioinformatics-based drug repositioning and prediction of the main active ingredients and potential mechanisms of action for the efficacy of Dan-Lou tablet
Jingyue Zhang, Zhaozhou Lin, Yinghua Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Jingyue Zhang, Zhaozhou Lin, Yinghua Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Elucidating the Mechanism of Traditional Chinese Medicine Formula (Yifei-sanjie Pill) in Alleviating the Chemobrain Based on Network Pharmacology and Experimental Verification
Yingchao Wu, Hui Wang, Liang Zheng, et al.
Journal of Traditional and Complementary Medicine (2024)
Open Access
Yingchao Wu, Hui Wang, Liang Zheng, et al.
Journal of Traditional and Complementary Medicine (2024)
Open Access
A Bioinformatics-Based Analysis of an Cuproptosis and Ferroptosis-Related Gene Signature Predicts the Prognosis of Patients with lung adenocarcinoma
Xizhi Liu, Shanzhi Gu, Xinhan Zhao, et al.
Research Square (Research Square) (2023)
Open Access
Xizhi Liu, Shanzhi Gu, Xinhan Zhao, et al.
Research Square (Research Square) (2023)
Open Access
